Clinical Trials

Heart disease study in patients with type 2 diabetes

Posted on 7/25/2019

This study is being done to assess whether the type 2 diabetes medicine, semaglitide, has a positive effect on heart disease.  This will be done by comparing it to placebo (no active ingredients).  This will be an oral tablet taken daily in the morning on an empty stomach.

You may qualify for this study if you:
  • Have type 2 diabetes
  • Have or had heart disease, certain diseases of the arteries and /or kidney disease
  • Are at least 50 years of age 

The study duration is approximately 3-5 years.  There will be 25 visits to the clinic, however after the first 3 months, you will only come to the clinic every 3 months.

There will be no charge for participating in the study.  The study medication, study materials and study specific visits will be provided at no charge to you or your insurance company. 

If you qualify and decide to participate you will be compensated for your time and travel while participating in the study.  

You will receive $50 for each study visit for a total of up to $1,300.

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
Everyone at DCOL Research is friendly and helpful. They all have a great sense of humor, which really helps you relax.  I have participated in several studies with them and the research coordinator I see is awesome. She makes you feel that your health is her top priority.  The research doctor is really good too and if you start having problems during the study he will take care of you. This research clinic is like a family, and once you participate in a study, you are just part of the family.     R. O.

Contact Form


  
DCOL of Longview